Hodgkin’s tumours disappear in coronavirus patient: case
COVID-19 may have caused a transient anti-tumour response in the 61-year-old man, say UK doctors
Doctors suspect COVID-19 may have caused a patient’s Hodgkin’s lymphoma tumours to virtually disappear, saying the virus may have sparked an anti-tumour response in the man.
The 61-year-old UK patient was diagnosed with Epstein-Barr virus (EBV)–positive classical Hodgkin’s lymphoma at the Royal Cornwall Hospital in Truro last year.
A fluorodeoxyglucose PET CT scan revealed that he had stage III disease, the doctors reported in the British Journal of Haematology.
Shortly after that diagnosis he was admitted to the hospital with COVID-19, and was discharged after 11 days of supportive, ward‐based care.
